133 related articles for article (PubMed ID: 7162342)
1. Selectivity of minimum structure enkephalins.
Vavrek RJ; Cui RL; Stewart JM
Life Sci; 1982 Nov 15-22; 31(20-21):2249-52. PubMed ID: 7162342
[TBL] [Abstract][Full Text] [Related]
2. Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.
Vavrek RJ; Cui RL; York EJ; Stewart JM; Paterson S; Kosterlitz HW
Life Sci; 1983; 33 Suppl 1():451-4. PubMed ID: 6319902
[TBL] [Abstract][Full Text] [Related]
3. Minimum structure opioids-dipeptide and tripeptide analogs of the enkephalins.
Vavrek RJ; Hsi LH; York EJ; Hall ME; Stewart JM
Peptides; 1981; 2(3):303-8. PubMed ID: 6272246
[TBL] [Abstract][Full Text] [Related]
4. Receptor binding and biological activity of bivalent enkephalins.
Costa T; Wüster M; Herz A; Shimohigashi Y; Chen HC; Rodbard D
Biochem Pharmacol; 1985 Jan; 34(1):25-30. PubMed ID: 2981528
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs].
Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA
Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
7. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
[TBL] [Abstract][Full Text] [Related]
9. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
Audigier Y; Mazarguil H; Gout R; Cros J
Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides.
Schiller PW; Nguyen TM; DiMaio J; Lemieux C
Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
13. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
[TBL] [Abstract][Full Text] [Related]
14. Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity.
Mosberg HI; Hurst R; Hruby VJ; Galligan JJ; Burks TF; Gee K; Yamamura HI
Life Sci; 1983 May; 32(22):2565-9. PubMed ID: 6304440
[TBL] [Abstract][Full Text] [Related]
15. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
Sánchez-Blázquez P; Garzón J
Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
[TBL] [Abstract][Full Text] [Related]
16. Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors.
Gacel G; Fournié-Zaluski MC; Fellion E; Roques BP
J Med Chem; 1981 Oct; 24(10):1119-24. PubMed ID: 6276540
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
Edwards JV; Spatola AF; Lemieux C; Schiller PW
Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
[TBL] [Abstract][Full Text] [Related]
18. A quantitative structure-activity relationship study of the inhibitory action of a series of enkephalin-like peptides in the guinea pig ileum and mouse vas deferens bioassays.
Fauchère JL
J Med Chem; 1982 Dec; 25(12):1428-31. PubMed ID: 7154003
[TBL] [Abstract][Full Text] [Related]
19. Selective ligands for opioid receptors. beta-Cyclopropylalanyl containing analogs of enkephalin.
Muthukumaraswamy N; Day AR; Pinon D; Liao CS; Freer RJ
Int J Pept Protein Res; 1983 Sep; 22(3):305-12. PubMed ID: 6313538
[No Abstract] [Full Text] [Related]
20. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M
J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
